Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01017198 · ClinicalTrials.gov registry record · Phase 1
Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors
A Phase 1 study, sponsored by Biogen.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT01017198 is a Phase 1 study that has completed, run by Biogen. The registered enrollment target is 20 participants.
The verdict
NCT01017198, a Phase 1 study, has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is designed to assess the effect of food and antacid use on the pharmacokinetic properties of BIIB021.
Interventions
- DRUG BIIB021 and Food
- DRUG BIIB0121 and Antacid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01017198
The ClinicalTrials.gov registry entry for NCT01017198 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BIIB021 and Food is the first listed.
NCT01017198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01017198 about?
NCT01017198 is a clinical study titled "Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors". This study is designed to assess the effect of food and antacid use on the pharmacokinetic properties of BIIB021.
What is the current status of trial NCT01017198?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2009-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01017198?
The interventions under investigation include: BIIB021 and Food (DRUG), BIIB0121 and Antacid (DRUG).
Who is sponsoring clinical trial NCT01017198?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.